Peer Exchange

  

Advances in the Treatment of Alzheimer


An expert panel reviews the causes of Alzheimer disease, as well as strategies used to detect mild cases and cognitive impairment.

Key opinion leaders break down what is needed to make a diagnosis of Alzheimer disease while working alongside primary care physicians.

After emphasizing the importance of early recognition and diagnosis, panelists reflect on available assessment scales for Alzheimer disease.

Comprehensive recommendations for genetic testing in the context of treating Alzheimer disease.

The panel defines what imaging physicians should utilize, and what they should look for, while diagnosing a patient with Alzheimer disease.

A brief review of brain health strategies and their value in the Alzheimer disease treatment paradigm.

In the context of modern agents used to treat Alzheimer disease, experts define what the goals of treatment and response should be.

Modern strategies used to inform the management of Alzheimer disease, particularly blood tests and the role of protofibrils, are considered.

Experts elucidate amyloid-targeted strategies in Alzheimer disease, including monoclonal antibodies and BACE inhibitors.

A future look at the role of amyloid-targeted strategies in Alzheimer disease and practical considerations for their use.

Concluding its discussion on Alzheimer disease, the panel provides closing considerations on future diagnosis and pharmacologic strategies.
SAP Partner Banner